Technical Analysis for OGEN - Oragenics, Inc.

Grade Last Price % Change Price Change
grade D 0.43 1.42% 0.01
OGEN closed up 1.42 percent on Friday, October 11, 2019, on 18 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical OGEN trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Bullish Engulfing Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion 1.42%
Down 3 Days in a Row Weakness 1.42%
Down 4 Days in a Row Weakness 1.42%
Down 5 Days in a Row Weakness 1.42%

Older signals for OGEN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Oragenics, Inc., a healthcare company, engages in the discovery, development, and commercialization of various technologies associated with oral health, antibiotics, and other general health benefits in the United States and internationally. It develops ProBiora3, an oral care probiotics technology for oral health, teeth whitening, and breath freshening for humans and pets. The company's ProBiora3 products include flavored probiotic tablets, such as EvoraPlus for daily use by adults and EvoraKids for daily use by children after brushing their teeth; EvoraPet for companion pets, including cats and dogs; and EvoraPro, a professional strength version of EvoraPlus. Its product pipeline consists of LPT3-04, a naturally occurring compound for weight loss; SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay; and MU1140-S, an antibiotic product candidate in preclinical testing for healthcare-associated infections. Oragenics, Inc. offers its ProBiora3 products through direct-to-consumer channels, professional offices, and private label partnerships. The company was formerly known as Oragen, Inc. The company was founded in 1996 and is headquartered in Tampa, Florida.
Medicine Health Healthcare Health Care Antibiotics Antibiotic Healthcare Associated Infections Bacteriology Digestive System Oral Hygiene Tooth Whitening
Is OGEN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.67
52 Week Low 0.35
Average Volume 962,790
200-Day Moving Average 0.6093
50-Day Moving Average 0.4592
20-Day Moving Average 0.513
10-Day Moving Average 0.4618
Average True Range 0.0468
ADX 20.44
+DI 15.9535
-DI 21.4853
Chandelier Exit (Long, 3 ATRs ) 0.5495999999999999
Chandelier Exit (Short, 3 ATRs ) 0.5604
Upper Bollinger Band 0.6386
Lower Bollinger Band 0.3874
Percent B (%b) 0.17
BandWidth 48.966862
MACD Line -0.015
MACD Signal Line 0.0008
MACD Histogram -0.0158
Fundamentals Value
Market Cap 21.18 Million
Num Shares 49.3 Million
EPS -0.16
Price-to-Earnings (P/E) Ratio -2.70
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.46
Resistance 3 (R3) 0.46 0.45 0.46
Resistance 2 (R2) 0.45 0.44 0.45 0.45
Resistance 1 (R1) 0.44 0.44 0.45 0.44 0.45
Pivot Point 0.43 0.43 0.43 0.43 0.43
Support 1 (S1) 0.42 0.42 0.43 0.42 0.41
Support 2 (S2) 0.41 0.42 0.41 0.41
Support 3 (S3) 0.40 0.41 0.41
Support 4 (S4) 0.40